Men in England & Wales miss out on abiraterone as first-line treatment for advanced prostate cancer: The Institute of Cancer Research, London, has expressed disappointment at the decision by NICE not to recommend abiraterone as a first-line treatment on the NHS for newly diagnosed, advanced prostate cancer. The decision puts the NHS in England and Wales out […]
Read More… from Prostate cancer treatment abiraterone not available